Our mission is to build technologies that break barriers to access and increase the effectiveness of gene therapies for children with neuro-genetic diseases. Our primary disease targets are Mucopolysaccharidoses: MPS I, MPS II, MPS IIIA, MPS IIIB, MPS IIIC
View Top Employees from NeuroGT, Inc.Employees | 1 (0 on RocketReach) |
Industry | Biotechnology |
Looking for a particular NeuroGT, Inc. employee's phone or email?